Lipid profile in maintenance haemodialysis;Profil lipidique dans l'insuffisance rénale chronique au stade d'hémodialyse

Pathologie Biologie

Volumn 53, Issue 4, 2005, Pages 217-220

  Jamoussi, K ^a,b   Ayedi, F ^a,b   Abida, N ^a   Kamoun, K ^c   Feki H ^c   Chaabouni, M N ^d   Hammouda, F ^d   Bahloul, I ^d   Bellaj, A ^d   Hachicha, J ^c   Ellouz, F ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b UNIVERSITY OF SFAX   (Tunisia)

^c HEDI CHAKER HOSPITAL   (Tunisia)

^d Polyclinique Essalema   (Tunisia)

Author keywords

Apolipoproteins; Atherosclerosis; Chronic kidney failure; Haemodialysis; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; HEMODIALYSIS; HUMAN; LIPID ANALYSIS; MALE; POPULATION RESEARCH; THEORETICAL STUDY; TUNISIA;

EID: 20944442871     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.07.015     Document Type: Article

References (12)

1. B. Moulin Anomalies lipidiques au cours de l'insuffisance ŕnale:: conśquences sur la progression de l'insuffisance ŕnale et le risque cardiovasculaire Ńphrologie 21 2000 339 341
2. M. Nauck, A. Krämer-Guth, W. Bartens, W. März, H. Wieland, and C. Wanner Is the determination of LDL cholesterol according to Friedwald accurate in CAPD and HD patients? Clin. Nephrol. 46 1996 319 325
3. G. Sigurdsson, A. Baldursdottir, H. Sigvaldason, U. Agnarsson, G. Thorgeirsson, and N. Sigfusson Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men Am. J. Cardiol. 69 1992 1251 1254
4. S.C. Smith, P. Greenland, and S.M. Grundy Prevention conference:V. beyond secondary prevention: identifying the high-risk patient for primary prevention. Executive summary Circulation 101 2000 111 116
5. T. Shoji, E. Ishimura, M. Inaba, T. Tabata, and Y. Nishizawa Atherogenic lipoproteins in end-stage renal disease Am J Kidney Dis 38 4:suppl:1 2001 S30 S33
6. A. Verzola, L. Perini, S. Gatto, P. Gilli, and P.L. Bedani Causes and risks of hyperlipidemia during dialysis and after renal transplantation Recenti Prog. Med. 89 1998 590 597
7. B. Lacour, Z.A. Massy, P. Jungers, and T. Drucke Anomalies du ḿtabolisme des lipoprot́ines dans l'insuffisance ŕnale chronique Nephrologie 14 1993 75 90
8. M. Elisaf, H.T. Bairaktari, C. Tzallas, N. Germanos, E. Koulouridis, and M. Pappas Lipid parameters including Lp(a) in hemodialysis patients Ren. Fail. 16 1994 501 509
9. C. Baigent, K. Burbury, and D. Wheeler Premature cardiovascular disease in chronic renal failure Lancet 356 2000 147 152
10. J. Frey, and R. Couderc Valeur śmiologique du cholest́rol- LDL et de l'apolipoprot́ine B dans le risque ath́romateux Ann. Biol. Clin. (Paris) 56 1998 517 520
11. B. Kinosian, H. Glick, L. Preiss, and K.L. Puder Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios J. Investig. Med. 43 1995 443 450
12. M. De Lorgeril, and P. Salen Acides gras oḿga-3, antioxydants et dìte ḿditerrańenne:: nouvelles strat́gies nutritionnelles pour la pŕvention et le traitement des maladies cardiovasculaires isch́miques S.T.V. 12 2000 202 210